273 related articles for article (PubMed ID: 18474570)
1. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
[TBL] [Abstract][Full Text] [Related]
3. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
4. Prion infection impairs cholesterol metabolism in neuronal cells.
Cui HL; Guo B; Scicluna B; Coleman BM; Lawson VA; Ellett L; Meikle PJ; Bukrinsky M; Mukhamedova N; Sviridov D; Hill AF
J Biol Chem; 2014 Jan; 289(2):789-802. PubMed ID: 24280226
[TBL] [Abstract][Full Text] [Related]
5. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
6. Normal host prion protein necessary for scrapie-induced neurotoxicity.
Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
[TBL] [Abstract][Full Text] [Related]
7. In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie.
Thorne L; Terry LA
J Gen Virol; 2008 Dec; 89(Pt 12):3177-3184. PubMed ID: 19008409
[TBL] [Abstract][Full Text] [Related]
8. PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.
Paquet S; Daude N; Courageot MP; Chapuis J; Laude H; Vilette D
J Virol; 2007 Oct; 81(19):10786-91. PubMed ID: 17626095
[TBL] [Abstract][Full Text] [Related]
9. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.
Taraboulos A; Scott M; Semenov A; Avrahami D; Laszlo L; Prusiner SB
J Cell Biol; 1995 Apr; 129(1):121-32. PubMed ID: 7698979
[TBL] [Abstract][Full Text] [Related]
11. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
12. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
[TBL] [Abstract][Full Text] [Related]
14. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.
Mallucci G; Dickinson A; Linehan J; Klöhn PC; Brandner S; Collinge J
Science; 2003 Oct; 302(5646):871-4. PubMed ID: 14593181
[TBL] [Abstract][Full Text] [Related]
15. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
Weissmann C
FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.
Koukouli F; Paspaltsis I; Salta E; Xanthopoulos K; Koini EN; Calogeropoulou T; Sklaviadis T
Prion; 2012; 6(5):470-6. PubMed ID: 22918434
[TBL] [Abstract][Full Text] [Related]
17. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.
Vey M; Pilkuhn S; Wille H; Nixon R; DeArmond SJ; Smart EJ; Anderson RG; Taraboulos A; Prusiner SB
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14945-9. PubMed ID: 8962161
[TBL] [Abstract][Full Text] [Related]
18. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
Vorberg I; Raines A; Priola SA
J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
[TBL] [Abstract][Full Text] [Related]
19. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells.
Borchelt DR; Scott M; Taraboulos A; Stahl N; Prusiner SB
J Cell Biol; 1990 Mar; 110(3):743-52. PubMed ID: 1968466
[TBL] [Abstract][Full Text] [Related]
20. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
